logo
Select company
Select metric
$ -38.18MConsolidated Income
VS
Market
22
Sector
44
Industry
57
History
71
$ 1.75Close
$ 0.26 - $ 1.84 52-Week Range
Ticker Information

Ticker

OVID

Company Name

OVID THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OVID THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OVID - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -38.18M
3/31/2025$ -24.97M
12/31/2024$ -26.43M
9/30/2024$ -32.5M
6/30/2024$ -29.75M
3/31/2024$ -50.68M
12/31/2023$ -52.34M
9/30/2023$ -48.52M
6/30/2023$ -49.24M
3/31/2023$ -51.42M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OVID THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -75.98M.
  • Over the past 5 years, OVID THERAPEUTICS INC's average Cons. Inc. has been $ -16.74M.
  • The median Cons. Inc. for OVID THERAPEUTICS INC during this period was $ -48.88M
  • OVID THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ 126.81M.
  • The lowest Cons. Inc. recorded by OVID THERAPEUTICS INC in the same timeframe $ -81.04M

OVID THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
VERU : VERU INC $ -32.71MCUE : CUE BIOPHARMA INC $ -38.9MPSTV : PLUS THERAPEUTICS INC $ -19.03MCBUS : CIBUS INC $ -303.21MTCRX : TSCAN THERAPEUTICS INC $ -136.78MCRVO : CERVOMED INC $ -22.61MALGS : ALIGOS THERAPEUTICS INC $ -74.18MPYXS : PYXIS ONCOLOGY INC $ -96.29MNTRB : NUTRIBAND INC $ -10.27MARMP : ARMATA PHARMACEUTICALS INC $ -25.71M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

OVID - Consolidated Income, Last 5 years

$ -81.04M

Minimum

Dec 31, 2020

$ 126.81M

Maximum

Sep 30, 2021

$ -16.74M

Average

$ -48.88M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M